Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Thyroid cytology: evaluation and perspectives]

C de Micco1

  • 1Faculté de Médecine Nord, Laboratoire d'Anatomie Pathologique, Marseille.

Annales D'Endocrinologie
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of [¹¹¹In]pentetreotide-SPECT and [¹⁸F]FDOPA-PET in the localization of extra-adrenal paragangliomas: the case for a patient-tailored use of nuclear imaging modalities.

Clinical endocrinology·2010
Same author

Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal.

The Journal of clinical endocrinology and metabolism·2010
Same author

Mild hypercalcitoninaemia and sporadic thyroid disease.

The British journal of surgery·2010
Same author

Tumor protein p53-induced nuclear protein (TP53INP1) expression in medullary thyroid carcinoma: a molecular guide to the optimal extent of surgery?

World journal of surgery·2010
Same author

Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia.

The Journal of clinical endocrinology and metabolism·2009
Same author

Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study.

Clinical endocrinology·2008
Same journal

Corrigendum to 'Pink adipose tissue: A paradigm of adipose tissue plasticity' [Ann. Endocrinol. 85 (2004) 248-51].

Annales d'endocrinologie·2026
Same journal

Intraoperative location of parathyroid glands during total thyroidectomy: a systematic review of the literature according to the PRISMA method.

Annales d'endocrinologie·2026
Same journal

Clinical and genetic diagnosis of PHP1A associated with hypogonadism in a young male: A case report.

Annales d'endocrinologie·2026
Same journal

Autoimmune features in acquired generalized lipodystrophy and anti-perilipin 1 antibodies: A case report.

Annales d'endocrinologie·2026
Same journal

The diagnostic challenge of occult glucocorticoid exposure causing Cushing's syndrome.

Annales d'endocrinologie·2026
Same journal

ACTH-dependent Cushing's syndrome in MEN1: When multiple tumors complicate the diagnosis.

Annales d'endocrinologie·2026
See all related articles

Fine needle aspiration cytology is a key diagnostic tool for thyroid nodules. Immunodetection of thyroid peroxidase (TPO) shows promise for improving cancer diagnostic accuracy.

Area of Science:

  • Endocrinology
  • Oncology
  • Pathology

Context:

  • Thyroid nodules are common, requiring accurate diagnostic methods.
  • Fine needle aspiration (FNA) cytology is the primary initial investigation.
  • Current FNA limitations include sampling variability and false negatives.

Purpose:

  • To describe FNA procedures and results for thyroid nodules.
  • To evaluate immunocytochemical detection of malignancy markers.
  • To assess the efficacy of thyroid peroxidase (TPO) immunodetection.

Summary:

  • FNA cytology categorizes thyroid nodules as benign, intermediate, or malignant.
  • Standard FNA achieves 90-95% sensitivity and 65-75% specificity for cancer detection.
  • Immunodetection of TPO in FNA specimens offers potential for 100% sensitivity and >90% specificity.

Related Experiment Videos

Impact:

  • Enhanced diagnostic accuracy for thyroid cancer.
  • Improved patient management and treatment strategies.
  • Potential reduction in unnecessary surgeries and improved outcomes.